Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Specific TT virus sequences and chimeric TT virus host cell DNA molecules for use in diagnosis, prevention and treatment of cancer and autoimmunity

Specific TT virus sequences and chimeric TT virus host cell DNA molecules for use in diagnosis, prevention and treatment of cancer and autoimmunity

US Patent 9624511 · Granted Apr 18, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of BMMFI Rep protein as biomarker for colorectal cancer2025
Crystal structure of a replication protein encoded by a plasmid isolated from a 2025
Rep protein as protein antigen for use in diagnostic assays2023
Rep protein for use in a diagnostic assay2021
TTV miRNA sequences as an early marker for the future development of cancer and 2019
HCBI sequences as an early marker for the future development of cancer and disea2019
HCBI sequences as an early marker for the future development of cancer and disea2019
Rearranged TT virus molecules for use in diagnosis, prevention and treatment of 2017
Rearranged TT virus molecules for use in diagnosis, prevention and treatment of 2017
Modified HPV E6 and E7 genes and proteins useful for vaccination2010
Papilloma viruses, products for the detection thereof as well as for treating di2003
Papilloma viruses, means for the detection thereof and therapy for diseases caus2003